Forget incineration or landfills. To resolve the increasing, never-ending waste stream of medical PPE as a result of the pandemic, Cornell engineers suggest recycling via pyrolysis.
Blockchain technology expert Ari Juels testified Jan. 20 before a Congressional subcommittee that digital currency – a notorious energy guzzler – can be validated in greener ways.
By mapping all the protein interactions of a dementia-linked protein in the brain called Tau, a team of Weill Cornell Medicine investigators has created a road map for identifying potential new treatment targets for Alzheimer’s disease and related dementia.
Cornell startups Ava Labs have new key partnerships with Deloitte and Mastercard, while university startup companies SwiftScale Biologics and Novomer have been acquired.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
An interdisciplinary seminar in the fall semester took students from Ithaca to New York City to explore African American heritage sites and the people whose work keeps this history alive.
For the Northeastern U.S., the year 2021 was third warmest – at an average of 49.5 degrees, which ties the year 2020 – since 1895, says the Northeast Regional Climate Center.
Professors Neil Lewis Jr. ’13 and Tashara Leak are leading the new Action Research Collaborative, which will serve as an institutional hub for cross-campus action research collaborations between Ithaca and New York City, and elsewhere.
COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine.
